Cumberland Pharmaceuticals, Inc (CPIX) Covered Calls

Cumberland Pharmaceuticals, Inc covered calls Cumberland Pharmaceuticals Inc. focuses on acquiring rights to, developing, and commercializing prescription products for the acute care and gastroenteritis markets.

You can sell covered calls on Cumberland Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CPIX (prices last updated Tue 4:16 PM ET):

Cumberland Pharmaceuticals, Inc (CPIX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
6.35 +0.05 6.02 6.95 14K - 0.1B
Covered Calls For Cumberland Pharmaceuticals, Inc (CPIX)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jul 19 7.5 0.00 6.95 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is focused on the acquisition, development and commercialization of branded prescription products. The company's primary target markets include hospital acute care and gastroenterology. Its product portfolio includes Acetadote injection for the treatment of acetaminophen poisoning; Caldolor injection for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren injection, a phase II candidate for the treatment of critically ill hospitalized patients suffering from liver and kidney failure associated with hepatorenal syndrome; and Boxaban oral capsules, a phase II candidate for the treatment of patients with aspirin-exacerbated respiratory disease. Cumberland Pharmaceuticals was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.